Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
ZM
|
Sc Us (Ttgp), Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 828,437 Reduced 100.0% |
$28,332,546
$34.2 p/Share
|
Apr 23
2019 |
|
ZM
|
Carl M. Eschenbach
Director |
SELL
Open market or private sale
|
Indirect | 828,437 Reduced 100.0% |
$28,332,546
$34.2 p/Share
|
Apr 23
2019 |
|
ZM
|
Janine Pelosi
Chief Marketing Officer |
SELL
Open market or private sale
|
Direct | 81,668 Reduced 100.0% |
$2,940,048
$36.0 p/Share
|
Apr 23
2019 |
|
ZM
|
Eric S. Yuan
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 583,787 Reduced 100.0% |
$21,016,332
$36.0 p/Share
|
Apr 23
2019 |
|
RF
|
John B Owen
SEVP & COO |
SELL
Open market or private sale
|
Direct | 61,756 Reduced 32.69% |
$941,779
$15.25 p/Share
|
Apr 23
2019 |
|
RF
|
Scott M. Peters
SEVP |
SELL
Open market or private sale
|
Direct | 30,877 Reduced 37.95% |
$469,022
$15.19 p/Share
|
Apr 23
2019 |
|
APEX
|
Cove Street Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 13,282 Reduced 0.34% |
$9,430
$0.71 p/Share
|
Apr 23
2019 |
|
WTM
|
Morgan W Davis
Director |
SELL
Open market or private sale
|
Indirect | 696 Reduced 16.38% |
$633,437
$910.11 p/Share
|
Apr 23
2019 |
|
ITRI
|
Scopia Capital Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 16,311 Reduced 0.38% |
$833,818
$51.12 p/Share
|
Apr 23
2019 |
|
ZM
|
Puccini World LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 223,124 Reduced 100.0% |
$7,630,841
$34.2 p/Share
|
Apr 23
2019 |
|
ZM
|
Bucantini Enterprises LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 507,243 Reduced 100.0% |
$17,347,711
$34.2 p/Share
|
Apr 23
2019 |
|
HOOK
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect | 892,857 Added 50.0% |
$12,499,998
$14.0 p/Share
|
Apr 23
2019 |
|
TGE
|
Blackstone Holdings Iii L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 13,064 Added 1.57% |
$319,937
$24.49 p/Share
|
Apr 23
2019 |
|
CZNC
|
Terry L Lehman |
BUY
Open market or private purchase
|
Direct | 460 Added 5.05% |
$12,737
$27.69 p/Share
|
Apr 23
2019 |
|
TPL
|
Horizon Kinetics LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 36 Added 0.02% |
$32,359
$898.87 p/Share
|
Apr 23
2019 |
|
CWH
|
Abrams Capital Management, L.P. |
BUY
Open market or private purchase
|
Indirect | 413,446 Added 8.66% |
$5,556,714
$13.44 p/Share
|
Apr 23
2019 |
|
ZM
|
Bucantini Enterprises LTD
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 350,000 Added 50.0% |
$12,600,000
$36.0 p/Share
|
Apr 23
2019 |
|
TRV
|
Jay S Benet
Vice Chairman |
SELL
Open market or private sale
|
Direct | 60,979 Reduced 41.53% |
$8,382,173
$137.46 p/Share
|
Apr 23
2019 |
|
TPL
|
Horizon Kinetics LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 36 Added 0.02% |
$32,259
$896.07 p/Share
|
Apr 22
2019 |
|
TPTX
|
Glaxosmithkline PLC
Director |
BUY
Open market or private purchase
|
Indirect | 325,000 Added 14.02% |
$5,850,000
$18.0 p/Share
|
Apr 22
2019 |
|
TPTX
|
Orbimed Advisors LLC
Director |
BUY
Open market or private purchase
|
Indirect | 360,000 Added 15.08% |
$6,480,000
$18.0 p/Share
|
Apr 22
2019 |
|
TPTX
|
Lu Hongbo
Director |
BUY
Open market or private purchase
|
Indirect | 60,000 Added 3.36% |
$1,080,000
$18.0 p/Share
|
Apr 22
2019 |
|
TPTX
|
Carl L Gordon
Director |
BUY
Open market or private purchase
|
Indirect | 360,000 Added 15.08% |
$6,480,000
$18.0 p/Share
|
Apr 22
2019 |
|
TPTX
|
Simeon George
Director |
BUY
Open market or private purchase
|
Indirect | 325,000 Added 14.02% |
$5,850,000
$18.0 p/Share
|
Apr 22
2019 |
|
TPTX
|
Brian Lee Baker
SVP of Finance and Admin. |
BUY
Open market or private purchase
|
Direct | 2,800 Added 50.0% |
$50,400
$18.0 p/Share
|
Apr 22
2019 |
|
TPTX
|
Athena Countouriotis
President & CEO |
BUY
Open market or private purchase
|
Direct | 12,000 Added 50.0% |
$216,000
$18.0 p/Share
|
Apr 22
2019 |
|
TGE
|
Blackstone Holdings Iii L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 400 Added 0.05% |
$9,796
$24.49 p/Share
|
Apr 22
2019 |
|
ABT
|
Randel William Woodgrift
SENIOR VICE PRESIDENT |
BUY
Open market or private purchase
|
Direct | 2,000 Added 3.67% |
$146,800
$73.4 p/Share
|
Apr 22
2019 |
|
TPTX
|
Cormorant Asset Management, LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 400,000 Added 11.43% |
$7,200,000
$18.0 p/Share
|
Apr 22
2019 |
|
K
|
Kellogg W K Foundation Trust |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 0.16% |
$5,853,000
$58.53 p/Share
|
Apr 22
2019 |
|
RNGR
|
B. Riley Financial, Inc. |
SELL
Open market or private sale
|
Indirect | 3,000 Reduced 1.59% |
$22,260
$7.42 p/Share
|
Apr 22
2019 |
|
SCHW
|
Charles R. Schwab
Co-Chairman |
SELL
Open market or private sale
|
Indirect | 250,000 Reduced 0.32% |
$11,322,500
$45.29 p/Share
|
Apr 22
2019 |
|
USB
|
Leslie V Godridge
Vice Chair |
SELL
Open market or private sale
|
Direct | 12,564 Reduced 24.21% |
$647,423
$51.53 p/Share
|
Apr 22
2019 |
|
MKL
|
Steven A Markel
Director |
SELL
Open market or private sale
|
Direct | 100 Reduced 0.1% |
$101,055
$1010.55 p/Share
|
Apr 22
2019 |
|
DAL
|
Edward H Bastian
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 7.81% |
$1,725,000
$57.5 p/Share
|
Apr 22
2019 |
|
ACN
|
Noordende Alexander M Van 'T
Group Chief Exec-Products |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 6.41% |
$1,422,240
$177.78 p/Share
|
Apr 22
2019 |
|
ACN
|
Julie Spellman Sweet
Chair and CEO |
SELL
Open market or private sale
|
Direct | 2,568 Reduced 13.46% |
$456,488
$177.76 p/Share
|
Apr 22
2019 |
|
ACN
|
Richard Lumb
Group Chief Executive-Fin Serv |
SELL
Open market or private sale
|
Direct | 18,000 Reduced 13.73% |
$3,200,040
$177.78 p/Share
|
Apr 22
2019 |
|
ACN
|
Daniel T London
Group Chief Exec - Health & PS |
SELL
Open market or private sale
|
Direct | 2,042 Reduced 7.11% |
$363,047
$177.79 p/Share
|
Apr 22
2019 |
|
ACN
|
Chad T Jerdee
General Counsel and CCO |
SELL
Open market or private sale
|
Direct | 2,441 Reduced 15.43% |
$433,937
$177.77 p/Share
|
Apr 22
2019 |
|
ACN
|
Richard P Clark
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 6,266 Reduced 31.28% |
$1,113,969
$177.78 p/Share
|
Apr 22
2019 |
|
ACN
|
Gianfranco Casati
CEO-Growth Markets |
SELL
Open market or private sale
|
Direct | 5,510 Reduced 10.69% |
$979,513
$177.77 p/Share
|
Apr 22
2019 |
|
AMR
|
Kevin Lee Stanley
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 1,987 Reduced 11.27% |
$110,378
$55.55 p/Share
|
Apr 22
2019 |
|
MA
|
Gilberto Caldart
President, International |
SELL
Open market or private sale
|
Direct | 46,772 Reduced 100.0% |
$11,277,197
$241.11 p/Share
|
Apr 22
2019 |
|
PEP
|
Marie T. Gallagher
SVP and Controller |
SELL
Open market or private sale
|
Direct | 7,800 Reduced 12.29% |
$982,722
$125.99 p/Share
|
Apr 22
2019 |
|
ABT
|
Jaime Contreras
Senior Vice President |
SELL
Open market or private sale
|
Indirect | 918 Reduced 29.19% |
$67,124
$73.12 p/Share
|
Apr 22
2019 |
|
AADI
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 7,100 Reduced 0.15% |
$6,887
$0.97 p/Share
|
Apr 22
2019 |
|
PM
|
Mario Masseroli
Pres., Latin America & Canada |
SELL
Open market or private sale
|
Direct | 1,200 Reduced 12.3% |
$101,184
$84.32 p/Share
|
Apr 22
2019 |
|
GL
|
Larry M Hutchison
Co-Chaiman |
SELL
Open market or private sale
|
Direct | 13,000 Reduced 2.13% |
$1,129,310
$86.87 p/Share
|
Apr 22
2019 |
|
GL
|
Gary L Coleman
Co-Chairman |
SELL
Open market or private sale
|
Direct | 13,000 Reduced 1.87% |
$1,133,080
$87.16 p/Share
|
Apr 22
2019 |